A
ACRC Studies | Poway, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Baricitinib
LY3009104
Methotrexate
TAK-079
SEL-212
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 8 total trials
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...
Enrolling
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab
Trial sponsors
M
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems